tiprankstipranks
Trending News
More News >
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
US Market

Lixte Biotechnology Holdings (LIXT) Financial Statements

Compare
97 Followers

Lixte Biotechnology Holdings Financial Overview

Lixte Biotechnology Holdings's market cap is currently $25.40M. The company's EPS TTM is $-1.594; its P/E ratio is -3.44; Lixte Biotechnology Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

Lixte Biotechnology Holdings Debt to Assets

Lixte Biotechnology Holdings Cash Flow

Lixte Biotechnology Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.